129 related articles for article (PubMed ID: 15663788)
1. Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with citalopram.
Berggard C; Damberg M; Oreland L
BMC Pharmacol; 2005 Jan; 5():1. PubMed ID: 15663788
[TBL] [Abstract][Full Text] [Related]
2. Phenelzine treatment increases transcription factor AP-2 levels in rat brain.
Damberg M; Berggård C; Oreland L
BMC Pharmacol; 2003 Aug; 3():10. PubMed ID: 12943557
[TBL] [Abstract][Full Text] [Related]
3. Common effects of chronically administered antipanic drugs on brainstem GABA(A) receptor subunit gene expression.
Tanay VM; Greenshaw AJ; Baker GB; Bateson AN
Mol Psychiatry; 2001 Jul; 6(4):404-12. PubMed ID: 11443524
[TBL] [Abstract][Full Text] [Related]
4. Chronic citalopram treatment induces time-dependent changes in the expression and DNA-binding activity of transcription factor AP-2 in rat brain.
Berggård C; Damberg M; Oreland L
Eur Neuropsychopharmacol; 2003 Jan; 13(1):11-7. PubMed ID: 12480117
[TBL] [Abstract][Full Text] [Related]
5. Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2.
Damberg M; Ekblom J; Oreland L
Life Sci; 2000 Dec; 68(6):669-78. PubMed ID: 11205881
[TBL] [Abstract][Full Text] [Related]
6. Levels of transcription factors AP-2alpha and AP-2beta in the brainstem are correlated to monoamine turnover in the rat forebrain.
Damberg M; Eller M; Tõnissaar M; Oreland L; Harro J
Neurosci Lett; 2001 Nov; 313(1-2):102-4. PubMed ID: 11684350
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor AP-2 and monoaminergic functions in the central nervous system.
Damberg M
J Neural Transm (Vienna); 2005 Oct; 112(10):1281-96. PubMed ID: 15959839
[TBL] [Abstract][Full Text] [Related]
8. Screening antidepressants in the chick separation-stress paradigm.
Feltenstein MW; Sufka KJ
Psychopharmacology (Berl); 2005 Aug; 181(1):153-9. PubMed ID: 15778882
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.
Balu DT; Hoshaw BA; Malberg JE; Rosenzweig-Lipson S; Schechter LE; Lucki I
Brain Res; 2008 May; 1211():37-43. PubMed ID: 18433734
[TBL] [Abstract][Full Text] [Related]
10. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.
Paslawski T; Treit D; Baker GB; George M; Coutts RT
Psychopharmacology (Berl); 1996 Sep; 127(1):19-24. PubMed ID: 8880939
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise.
Russo-Neustadt AA; Alejandre H; Garcia C; Ivy AS; Chen MJ
Neuropsychopharmacology; 2004 Dec; 29(12):2189-99. PubMed ID: 15199375
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine.
Parent MB; Habib MK; Baker GB
Biochem Pharmacol; 2000 May; 59(10):1253-63. PubMed ID: 10736426
[TBL] [Abstract][Full Text] [Related]
13. The antidepressant phenelzine enhances memory in the double Y-maze and increases GABA levels in the hippocampus and frontal cortex of rats.
Simpson SM; Hickey AJ; Baker GB; Reynolds JN; Beninger RJ
Pharmacol Biochem Behav; 2012 Jul; 102(1):109-17. PubMed ID: 22503968
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone.
Dwivedi Y; Rizavi HS; Pandey GN
Neuroscience; 2006; 139(3):1017-29. PubMed ID: 16500030
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response.
Heydendael W; Jacobson L
Brain Res; 2008 Oct; 1238():93-107. PubMed ID: 18761333
[TBL] [Abstract][Full Text] [Related]
16. Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine.
Matveychuk D; Nunes E; Ullah N; Aldawsari FS; Velázquez-Martínez CA; Baker GB
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():67-73. PubMed ID: 24607770
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenoceptors and antidepressants: possible 2-phenylethylamine mediation of chronic phenelzine effects.
McManus DJ; Mousseau DD; Paetsch PR; Wishart TB; Greenshaw AJ
Biol Psychiatry; 1991 Dec; 30(11):1122-30. PubMed ID: 1663791
[TBL] [Abstract][Full Text] [Related]
18. Effect of repeated administration of antidepressants on serotonin uptake sites in limbic and neocortical structures of rat brain determined by quantitative autoradiography.
Kovachich GB; Aronson CE; Brunswick DJ
Neuropsychopharmacology; 1992 Dec; 7(4):317-24. PubMed ID: 1476595
[TBL] [Abstract][Full Text] [Related]
19. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.
Ordway GA; Gambarana C; Tejani-Butt SM; Areso P; Hauptmann M; Frazer A
J Pharmacol Exp Ther; 1991 May; 257(2):681-90. PubMed ID: 1674532
[TBL] [Abstract][Full Text] [Related]
20. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine.
Burghardt NS; Sullivan GM; McEwen BS; Gorman JM; LeDoux JE
Biol Psychiatry; 2004 Jun; 55(12):1171-8. PubMed ID: 15184036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
